CRISPR’s use has vast potential in basic research to add to the understanding of cellular activity and in healthcare for precision therapies for today’s untreatable diseases. To date, some 30 clinical ...
Editas Medicine said today its lead candidate EDIT-101, an in vivo CRISPR gene editing treatment for Leber congenital amaurosis-10 (LCA10), showed positive initial clinical data showing it to be safe, ...
No audio available for this content. 1Spatial has launched 1Edit, a touchscreen compatible solution that offers fast and intuitive data-editing in the field or office, 1Spatial said. Trialed by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results